Contact this trialFirst, we need to learn more about you.
Nucleoside analogue
Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection
Recruiting5 awardsPhase 4
Toronto, Ontario
This trial will help researchers understand how the antiviral drug Tenofovir alafenamide helps to reduce liver inflammation in patients with chronic hepatitis B.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service